Sfoglia per Rivista JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study
2015-01-01 Bruyand, Mathias; Ryom, Lene; Shepherd, Leah; Fatkenheuer, Gerd; Grulich, Andrew; Reiss, Peter; De Wit, Stéphane; Darminio Monforte, Antonella; Furrer, Hansjakob; Pradier, Christian; Lundgren, Jens; Sabin, Caroline; D:A:D study, Group; Giacometti, Andrea
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis).
2007-01-01 Rusconi, S; Gianotti, N; Adorni, F; Boeri, E; Menzo, Stefano; Gonnelli, A; Micheli, V; Meraviglia, P; Trezzi, M; Paolini, E; Giacometti, Andrea; Corsi, P; Di Pietro, M; Monno, L; Punzi, G; Zazzi, M; ARCA Collaborative, Group
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.
2016-01-01 Di Biagio, Antonio; Cozzi Lepri, Alessandro; Prinapori, Roberta; Angarano, Gioacchino; Gori, Andrea; Quirino, Tiziana; De Luca, Andrea; Costantini, Andrea; Mussini, Cristina; Rizzardini, Giuliano; Castagna, Antonella; Antinori, Andrea; dʼArminio Monforte, Antonella
Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1-Infected Patients on Suppressive Antiretroviral Therapy: A Longitudinal Study.
2012-01-01 De Luca, A; de Gaetano Donati, K; Cozzi Lepri, A; Colafigli, M; De Curtis, A; Capobianchi, Mr; Antinori, A; Giacometti, Andrea; Magnani, G; Vullo, V; Cauda, R; Iacoviello, L; Monforte, Ad; and The ICoNA Foundation Study, Group
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study
2005-01-01 A., DARMINIO MONFORTE; A., COZZI LEPRI; A., Phillips; A., DE LUCA; R., Murri; C., Mussini; P., Grossi; A., Galli; T., Zauli; Montroni, Maria; P., Tundo; M., Moroni
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study
2006-01-01 R., Murri; A., COZZI LEPRI; P., Cicconi; A., Poggio; M., Arlotti; G., Tositti; D., Santoro; Ml, Doranzo; G., Rizzardini; V., Colangeli; Montroni, Maria
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013
2014-01-01 d'Arminio Monforte, Antonella; Galli, Laura; Lo Caputo, Sergio; Lichtner, Miriam; Pinnetti, Carmela; Bobbio, Nicoletta; Francisci, Daniela; Costantini, Andrea; Cingolani, Antonella; Castelli, Francesco; Girardi, Enrico; Castagna, Antonella; ICONA Foundation Study, Group
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure.
2000-01-01 Balotta, C; Violin, M; Monno, L; Bagnarelli, Patrizia; Riva, C; Facchi, G; Berlusconi, A; Lippi, M; Rusconi, S; Clementi, M; Galli, M; Angarano, G; Moroni, M.
Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort
2017-01-01 Vita, Serena; Lichtner, Miriam; Marchetti, Giulia; Mascia, Claudia; Merlini, Esther; Cicconi, Paola; Vullo, Vincenzo; Viale, Pierluigi; Costantini, Andrea; DʼArminio Monforte, Antonella
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
2009-01-01 Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Moioli, C; Rizzardini, G; UBERTI FOPPA, C; Puoti, M; Monforte, Ad; HEPA I. C. O. N. A., THE ICONA FOUNDATION STUDY GROUPS; Montroni, Maria
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study | 1-gen-2015 | Bruyand, Mathias; Ryom, Lene; Shepherd, Leah; Fatkenheuer, Gerd; Grulich, Andrew; Reiss, Peter; De Wit, Stéphane; Darminio Monforte, Antonella; Furrer, Hansjakob; Pradier, Christian; Lundgren, Jens; Sabin, Caroline; D:A:D study, Group; Giacometti, Andrea | |
| Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis). | 1-gen-2007 | Rusconi, S; Gianotti, N; Adorni, F; Boeri, E; Menzo, Stefano; Gonnelli, A; Micheli, V; Meraviglia, P; Trezzi, M; Paolini, E; Giacometti, Andrea; Corsi, P; Di Pietro, M; Monno, L; Punzi, G; Zazzi, M; ARCA Collaborative, Group | |
| Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy. | 1-gen-2016 | Di Biagio, Antonio; Cozzi Lepri, Alessandro; Prinapori, Roberta; Angarano, Gioacchino; Gori, Andrea; Quirino, Tiziana; De Luca, Andrea; Costantini, Andrea; Mussini, Cristina; Rizzardini, Giuliano; Castagna, Antonella; Antinori, Andrea; dʼArminio Monforte, Antonella | |
| Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1-Infected Patients on Suppressive Antiretroviral Therapy: A Longitudinal Study. | 1-gen-2012 | De Luca, A; de Gaetano Donati, K; Cozzi Lepri, A; Colafigli, M; De Curtis, A; Capobianchi, Mr; Antinori, A; Giacometti, Andrea; Magnani, G; Vullo, V; Cauda, R; Iacoviello, L; Monforte, Ad; and The ICoNA Foundation Study, Group | |
| Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study | 1-gen-2005 | A., DARMINIO MONFORTE; A., COZZI LEPRI; A., Phillips; A., DE LUCA; R., Murri; C., Mussini; P., Grossi; A., Galli; T., Zauli; Montroni, Maria; P., Tundo; M., Moroni | |
| Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study | 1-gen-2006 | R., Murri; A., COZZI LEPRI; P., Cicconi; A., Poggio; M., Arlotti; G., Tositti; D., Santoro; Ml, Doranzo; G., Rizzardini; V., Colangeli; Montroni, Maria | |
| Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 | 1-gen-2014 | d'Arminio Monforte, Antonella; Galli, Laura; Lo Caputo, Sergio; Lichtner, Miriam; Pinnetti, Carmela; Bobbio, Nicoletta; Francisci, Daniela; Costantini, Andrea; Cingolani, Antonella; Castelli, Francesco; Girardi, Enrico; Castagna, Antonella; ICONA Foundation Study, Group | |
| Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. | 1-gen-2000 | Balotta, C; Violin, M; Monno, L; Bagnarelli, Patrizia; Riva, C; Facchi, G; Berlusconi, A; Lippi, M; Rusconi, S; Clementi, M; Galli, M; Angarano, G; Moroni, M. | |
| Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort | 1-gen-2017 | Vita, Serena; Lichtner, Miriam; Marchetti, Giulia; Mascia, Claudia; Merlini, Esther; Cicconi, Paola; Vullo, Vincenzo; Viale, Pierluigi; Costantini, Andrea; DʼArminio Monforte, Antonella | |
| Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. | 1-gen-2009 | Morsica, G; Bagaglio, S; Cicconi, P; Capobianchi, Mr; Pellizzer, G; Caramello, P; Orani, A; Moioli, C; Rizzardini, G; UBERTI FOPPA, C; Puoti, M; Monforte, Ad; HEPA I. C. O. N. A., THE ICONA FOUNDATION STUDY GROUPS; Montroni, Maria |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile